Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen lays out a plan to “streamline” ops and add $400M to fund neurosciences R&D, growth
Biogen lays out a plan to “streamline” ops and add $400M to fund neurosciences R&D, growth
Biogen lays out a plan to “streamline” ops and add $400M to fund neurosciences R&D, growth
Submitted by
admin
on July 25, 2017 - 8:29am
Source:
Endpoints
News Tags:
Biogen
R&D
restructuring
Headline:
Biogen lays out a plan to “streamline” ops and add $400M to fund neurosciences R&D, growth
Do Not Allow Advertisers to Use My Personal information
